对宫癌有前途的预测性分子生物标志物 (评论)
Marcela Lizano1, Adela Carrillo-García1, Erick De La Cruz-Hernández2
1Unidad de Investigación Biomédica en Cáncer, Instituto Nacional de Cancerología, Universidad Nacional Autónoma de México, Mexico City 14080, Mexico.
International journal of molecular medicine
|April 12, 2024
概括
子宫癌 (CC) 仍然是一个全球性的健康挑战,特别是在低收入国家. 确定放射治疗反应的预测生物标志物对于精准医学和改善CC治疗结果至关重要.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 子宫癌 (CC) 构成了全球严重的健康负担,尽管由于疫苗接种和查导致发病率降低,但在低收入国家仍然存在高死亡率.
- 治疗CC的治疗策略取决于阶段,包括手术,放射治疗和化疗,但放射治疗的疗效在患者之间有很大差异.
- 放射电阻是一个重大的临床挑战,导致复发,转移,并强调需要预测生物标志物来指导个性化治疗.
结论:
- 识别患有放射治疗失败风险的患者对于定制治疗策略至关重要.
- 预测生物标志物可以通过考虑CC的遗传和表观遗传因素来实现个性化医疗.
- 对这些生物标志物的进一步研究可以显著改善治疗结果并降低CC死亡率.
相关概念视频
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...